seventeen alpha-hydroxylase deficiency

deficiência de 17-alfa-hidroxilase

Clicks: 187
ID: 238882
2006
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #188 of 246 articles by views in Bioorganic & medicinal chemistry letters

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 246 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Seventeen a-hydroxylase deficiency (17OHD) is a rare form of congenital adrenal hyperplasia in which defects in the biosynthesis of cortisol and sex steroid result in mineralocorticoid excess, hypokalemic hypertension and sexual abnormalities such as pseudohermaphroditism in males, and sexual infantilism in females. The disease is inherited in an autosomal recessive pattern, and is caused by mutations in the gene encoding cytochrome P450c17 (CYP17), which is the single polypeptide that mediates both 17α-hydroxylase and 17,20-lyase activities. We report the case of a 15-year-old patient with 17OHD who had a female phenotype but male karyotype (46,XY). The diagnosis was made based on classical clinical features, biochemical data and molecular genetic study. Two mutations were identified by polymerase chain reaction amplification and sequencing, including a S106P point mutation in exon 2 and a 9-bp (GACTCTTTC) deletion from nucleotide position 1519 in exon 8 of CYP17. The first of these mutations was found in the father and the second in the mother, and both have been previously reported in Asia. The patient's hypertension and hypokalemia resolved after glucocorticoid replacement and treatment with potassium-sparing diuretics. Sex hormone replacement was prescribed for induction of sexual development and reduction of the final height. Prophylactic gonadectomy was scheduled. In summary, 17OHD should be suspected in patients with hypokalemic hypertension and lack of secondary sexual development so that appropriate therapy can be implemented.
A deficiência de 17α-hidroxilase (17OHD) é uma forma rara de hiperplasia adrenal congênita na qual defeitos na biossíntese de cortisol e de esteroides sexuais resultam em excesso de mineralocorticoides, hipertensão hipocalêmica e anormalidades sexuais, tais como pseudo-hermafroditismo no sexo masculino e infantilismo sexual no sexo feminino. A doença apresenta padrão de herança autossômica recessiva e é causada por mutações no gene que codifica o citocromo P450c17 (CYP17), o único polipeptídeo que medeia tanto a atividade da 17α-hidroxilase quanto a da 17,20-liase. Relatamos o caso de uma paciente de 15 anos com 17OHD que apresentava fenótipo feminino, mas cariótipo masculino (46,XY). O diagnóstico foi estabelecido com base em características clínicas clássicas, dados bioquímicos e estudo genético-molecular. Duas mutações foram identificadas por amplificação por reação em cadeia da polimerase e sequenciamento, incluindo uma mutação pontual S106P no éxon 2 e uma deleção de 9 pb (GACTCTTTC) a partir da posição de nucleotídeo 1519 no éxon 8 do CYP17. A primeira dessas mutações foi encontrada no pai e a segunda na mãe, sendo que ambas já haviam sido previamente relatadas na Ásia. A hipertensão e a hipocalemia da paciente foram resolvidas após a reposição com glicocorticoide e o tratamento com diuréticos poupadores de potássio. A reposição de hormônios sexuais foi prescrita para a indução do desenvolvimento sexual e redução da estatura final. Foi programada gonadectomia profilática. Em resumo, deve-se suspeitar de 17OHD em pacientes com hipertensão hipocalêmica e ausência de desenvolvimento sexual secundário, para que a terapia adequada possa ser implementada.
Reference Key
wong2006journalseventeen Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Bioorganic & medicinal chemistry letters
Year 2006
DOI
10.1016/S0929-6646(09)60342-9
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.